Trial Information

Summary: An 8 week medication study for generalized anxiety disorder

A new medicine is being tested to determine if it is helpful to people with generalized anxiety disorder. Safety and tolerability of the medicine will also be assessed.

Patient Inclusion Criteria

  • 18 years or older with a diagnosis of Generalized Anxiety Disorder

Patient Exclusion Criteria

  • Major depressive order within last 6 months
  • Bipolar or psychotic disorder
  • illicit drug use confirmed by urine test

Contact:

Deb Shioshita, R.N.
Alpine Clinical Research Center
1000 Alpine Ave., Ste. 200
Boulder, CO 80304
Telephone: 303-443-7229 x108
Email:

Profile Page: Alpine Clinical Research Center, Boulder, CO

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:40 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA